Identification of prediagnostic proteomic biomarkers for colon and rectal cancer in 3 prospective cohorts.
It is found that pre-diagnostic plasma proteomics identified proteins and pathways with modest effect sizes and clear differences between future risk of colon and rectal cancer and motivate site-specific biomarker discovery that distinguishes colon from rectal cancer.